Some examples are PT2385 and PT2399, inhibitors of HIF-2α, thus inhibiting the expression of its dependent genes such as VEGF-A and cyclin D1, showing tumor regression in preclinical models for clear cell renal cell carcinomas [96,97]. This evidence concerns the gene VEGFA and neoplasm.